Advertisement
LabX
LabX

The Scientist

» geron

Most Recent

image: Geron hESC Trial to Resume?

Geron hESC Trial to Resume?

By | May 27, 2014

Nearly three years after Geron shuttered its stem cell program, BioTime receives funding to relaunch a Phase 1 trial for spinal cord injury.

0 Comments

image: Geron’s Stem Cell Program Sold

Geron’s Stem Cell Program Sold

By | October 2, 2013

The company, which launched the first ever clinical trial for a human embryonic stem cell therapy before shuttering its stem cell arm, has finally struck a deal with BioTime.

0 Comments

image: Geron Sells Stem Cell Assets

Geron Sells Stem Cell Assets

By | January 8, 2013

BioTime finalizes a deal to buy Geron’s defunct human embryonic stem cell assets.

0 Comments

image: BioTime Seeks Geron Stem Cell Assets

BioTime Seeks Geron Stem Cell Assets

By | November 13, 2012

Two former Geron CEOs make a bid for the company’s defunct human embryonic stem cell business.

1 Comment

image: First hESC Trial Kaput

First hESC Trial Kaput

By | November 15, 2011

Geron is terminating a clinical trial testing a human embryonic stem cell treatment for spinal cord injury.

30 Comments

Advertisement
LabX
LabX

Popular Now

  1. LabQuiz: What's Your Cell IQ?
    Sponsored Quiz LabQuiz: What's Your Cell IQ?

    Your body is made up of trillions of cells—but what do you really know about them? Take our lab quiz and determine your CIQ (cell identification quotient). 

  2. Antibody Maker Loses License Over Animal Welfare Violations
  3. Immune Defect Detected in Knockout Mice
  4. Exploring Emotional Contagion
Advertisement
Advertisement
LabX
LabX
Biosearch Technologies
illumina Corporate
illumina Corporate